Terns Pharmaceuticals, Inc.
TERN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$88,853 | -$90,210 | -$60,345 | -$50,158 |
| Dep. & Amort. | $896 | $881 | $1,032 | $512 |
| Deferred Tax | $23 | $141 | $392 | $219 |
| Stock-Based Comp. | $15,627 | $25,536 | $10,768 | $8,146 |
| Change in WC | $4,381 | $1,475 | -$1,037 | -$1,425 |
| Other Non-Cash | -$2,090 | -$5,213 | $81 | $879 |
| Operating Cash Flow | -$70,016 | -$67,390 | -$49,109 | -$41,827 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$42 | -$52 | -$275 | -$340 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$169,942 | -$275,781 | -$139,731 | -$166,297 |
| Inv. Sales/Matur. | $157,574 | $237,846 | $117,734 | $46,941 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12,410 | -$37,987 | -$22,272 | -$119,696 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$12,880 |
| Stock Issued | $162,312 | $41,611 | $167,253 | $136,362 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,683 | $340 | -$158 | $10,911 |
| Financing Cash Flow | $163,995 | $41,951 | $167,095 | $134,393 |
| Forex Effect | -$56 | $117 | -$178 | -$25 |
| Net Chg. in Cash | $81,513 | -$63,309 | $95,536 | -$27,155 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $79,926 | $143,235 | $47,699 | $74,854 |
| End Cash | $161,439 | $79,926 | $143,235 | $47,699 |
| Free Cash Flow | -$70,058 | -$67,442 | -$49,384 | -$42,167 |